<DOC>
	<DOCNO>NCT01172015</DOCNO>
	<brief_summary>Immunologic thrombcytopenic purpura ( ITP ) affect child adult . The incidence estimate adult 1,6/100 000/per year . Chronic relapse form disease represent 70 % adult case associate impairment quality life related treatment side effect bleed . ITP secondary destruction circulate platelet auto-immune process decrease platelet production bone marrow . Auto antibody usually direct epitope GPIIb/IIIa , express platelet . The destruction platelet seem occur mainly spleen antibody dependent cytotoxicity . Both macrophage cytotoxic T lymphocytes subset participate platelet destruction CD16 , low affinity receptor Fc IgG . Thus CD16 `` pathway '' target treatment ITP example intravenous immunoglobulin recently inhibitor syk kinase .</brief_summary>
	<brief_title>NATURAL KILLER CELLS IN IMMUNOLOGIC THROMBOCYTOPENIC PURpura Adults</brief_title>
	<detailed_description>Natural Killer cell ( NK ) cell , implicate pathophysiology several autoimmune disease , express CD16 display antibody dependent cytotoxicty . Moreover NK cell present human spleen . However role ITP study far . NK could represent new target treatment ITP . We propose thus conduct study characterize NK cell change patient ITP .</detailed_description>
	<mesh_term>Purpura , Thrombocytopenic</mesh_term>
	<mesh_term>Purpura</mesh_term>
	<criteria>ITP patient , platelet le 50000 G/L Secondary ITP ( VIH , VHC ... ) treatment Immunosuppressive agent except corticoid ( 10 mg/day ) treatment Ig IV le 3 week treatment Rifuximab le 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>